Cholinesterase Inhibitors - Administration & dosage
Research News and Information

Saturday, November 21, 2009

Acetylcholine-esterase inhibitor pyridostigmine decreases T cell overactivation in patients infected by HIV.

30 Jul 2009 HIV infection is characterized by persistent immune activation, increased production of proinflammatory cytokines, and rapid T cell turnover. The autonomic nervous system exerts a regulatory effect on the inflammatory response mediated by ... Read more...

Acetylcholinesterase inhibitor is a potentially useful therapeutic agent for nicotine-induced periodontal disease.

19 Jul 2009 Many cell types possess the essential components for a non-neuronal cholinergic system. These components include acetylcholine, choline acetyltransferase, acetylcholinesterase (AChE) and nicotinic acetylcholine receptors. Studies have indicated that ... Read more...

Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia.

29 Jun 2009 BACKGROUND: Impairment of multiple neurotransmitter networks, including acetylcholine, may contribute to the cognitive impairment in patients with Parkinson disease with dementia (PDD). Therefore, cholinesterase inhibitors might improve cognitive ... Read more...

Latest indexed articles for 'Cholinesterase Inhibitors - Administration & dosage'

These are the very latest articles for this heading:

• Case report: combined use of donepezil and galantamine in mixed dementia. 29 Sep 2009
• Acetylcholine-esterase inhibitor pyridostigmine decreases T cell overactivation in patients infected by HIV. 30 Jul 2009
• Epidural neostigmine: will it replace lipid soluble opioids for postoperative and labor analgesia? 30 Jul 2009
• Clinical investigation of neuraxially administered drugs: a regulatory perspective. 30 Jul 2009
• Acetylcholinesterase inhibitor is a potentially useful therapeutic agent for nicotine-induced periodontal disease. 19 Jul 2009
• Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia. 29 Jun 2009
• Plasma level of atropine after accidental ingestion of Atropa belladonna. 29 Jun 2009
• Cholinergic stimulation enhances neural activity associated with encoding but reduces neural activity associated with retrieval in humans. 22 Jun 2009
• Donepezil delays progression to AD in MCI subjects with depressive symptoms. 14 Jun 2009
• Central acetylcholinesterase inhibition improves hemodynamic counterregulation to severe blood loss in alcohol-intoxicated rats. 8 Jun 2009
• The cholinesterase inhibitor physostigmine for the local treatment of dry mouth: a randomized study. 30 May 2009
• Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan. 30 May 2009
• Improvements in limb kinetic apraxia by repetition of a newly designed facilitation exercise in a patient with corticobasal degeneration. 30 May 2009
• Cognitive-enhancing activity of loganin isolated from Cornus officinalis in scopolamine-induced amnesic mice. 25 May 2009
• Rivastigmine reduces tobacco craving in alcohol-dependent smokers. 16 May 2009
• Effects of epidural clonidine and neostigmine following intrathecal labour analgesia: a randomised, double-blind, placebo-controlled trial. 15 May 2009
• Cognitive performances of cholinergically depleted rats following chronic donepezil administration. 29 Apr 2009
• Effects of chronic donepezil treatment and cholinergic deafferentation on parietal pyramidal neuron morphology. 29 Apr 2009
• Two different doses of caudal neostigmine co-administered with levobupivacaine produces analgesia in children. 29 Apr 2009
• Effect of short-term exposure to dichlorvos on synaptic plasticity of rat hippocampal slices: involvement of acylpeptide hydrolase and alpha(7) nicotinic receptors. 16 Apr 2009

See a longer list of these articles.

Technical information about 'Cholinesterase Inhibitors'

Definition: Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.

Registry Number: 0

Descriptor UI: D002800

Alternative terms: Cholinesterase Inhibitors; Inhibitors, Cholinesterase; Anticholinesterase Drugs; Drugs, Anticholinesterase; Anticholinesterases; Anticholinesterase Agents; Agents, Anticholinesterase; Anti-Cholinesterases; Anti Cholinesterases; Cholinesterase Inhibitors, Irreversible; Inhibitors, Irreversible Cholinesterase; Irreversible Cholinesterase Inhibitors; Cholinesterase Inhibitors, Reversible; Inhibitors, Reversible Cholinesterase; Reversible Cholinesterase Inhibitors; Acetylcholinesterase Inhibitors; Inhibitors, Acetylcholinesterase;

Related Mesh Headings: Insecticides;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.519.389.275; D27.505.519.625.120.300; D27.505.696.577.120.300;

Online Note: use CHOLINESTERASE INHIBITORS to search CHOLINESTERASE INHIBITORS, IRREVERSIBLE & CHOLINESTERASE INHIBITORS, REVERSIBLE 1971-83 (as Prov 1971-74)

History Note: 65; CHOLINESTERASE INHIBITORS, IRREVERSIBLE & CHOLINESTERASE INHIBITORS, REVERSIBLE were see under CHOLINESTERASE INHIBITORS 1975-83, were Prov 1971-74; CHOLINESTERASE INHIBITORS, ORGANIC was see PHOSPHORUS POISONS, ORGANIC 1963-64 (PHOSPHORUS POISONS, ORGANIC deleted 1965)

Technical Notes: DF: CHOLINESTERASE INHIB